Teva elects Chen Lichtenstein to board effective Dec 1, 2024

TEVA PHARMACEUTICAL INDUSTRIES LTD

Chen Lichtenstein elected as independent director, effective Dec 1, 2024, until 2025 annual meeting.
Lichtenstein was CFO of Syngenta Group (2020-2023) and previously CEO of ADAMA Ltd.
He holds a Ph.D. in Business Administration from Stanford and multiple degrees from Hebrew University.
Compensation will be the same as Teva's other non-executive directors.
No material related-party transactions or family relationships with Teva executives.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Chen Lichtenstein

member of the Board

TEVA · TEVA PHARMACEUTICAL INDUSTRIES LTD

Effective: 2024-12-01
Filed: November 12, 2024, 6:59 PM ET

the Board elected Mr. Chen Lichtenstein to serve as a member of the Board, effective December 1, 2024

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Chen Lichtenstein was elected as member of the Board at TEVA PHARMACEUTICAL INDUSTRIES LTD.

Action: elected
Role: member of the Board

Exact text from the filing

the Board elected Mr. Chen Lichtenstein to serve as a member of the Board, effective December 1, 2024

View on SEC.gov

TEVA PHARMACEUTICAL INDUSTRIES LTD filing history →

Source: SEC EDGAR

accession 0001193125-24-256014

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.